JP Morgan Chase & Co’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $39M | Buy |
|
|||||
|
2025
Q2 | $31.6M | Sell |
|
|||||
|
2025
Q1 | $31.2M | Buy |
|
|||||
|
2024
Q4 | $32M | Buy |
|
|||||
|
2024
Q3 | $26M | Sell |
|
|||||
|
2024
Q2 | $35.2M | Sell |
|
|||||
|
2024
Q1 | $78.4M | Sell |
|
|||||
|
2023
Q4 | $70.7M | Buy |
|
|||||
|
2023
Q3 | $60.3M | Sell |
|
|||||
|
2023
Q2 | $74M | Sell |
|
|||||
|
2023
Q1 | $75.7M | Buy |
|
|||||
|
2022
Q4 | $86.1M | Sell |
|
|||||
|
2022
Q3 | $107M | Sell |
|
|||||
|
2022
Q2 | $105M | Sell |
|
|||||
|
2022
Q1 | $157M | Sell |
|
|||||
|
2021
Q4 | $164M | Buy |
|
|||||
|
2021
Q3 | $174M | Buy |
|
|||||
|
2021
Q2 | $145M | Buy |
|
|||||
|
2021
Q1 | $119M | Buy |
|
|||||
|
2020
Q4 | $118M | Buy |
|
|||||
|
2020
Q3 | $55.4M | Buy |
|
|||||
|
2020
Q2 | $70.5M | Buy |
|
|||||
|
2020
Q1 | $48.7M | Buy |
|
|||||
|
2019
Q4 | $56.2M | Buy |
|
|||||
|
2019
Q3 | $43.9M | Buy |
|
|||||
|
2019
Q2 | $58.8M | Sell |
|
|||||
|
2019
Q1 | $69.1M | Buy |
|
|||||
|
2018
Q4 | $46M | Buy |
|
|||||
|
2018
Q3 | $80.6M | Sell |
|
|||||
|
2018
Q2 | $77.6M | Sell |
|
|||||
|
2018
Q1 | $44.2M | Sell |
|
|||||
|
2017
Q4 | $50.4M | Buy |
|
|||||
|
2017
Q3 | $40.8M | Buy |
|
|||||
|
2017
Q2 | $24.2M | Buy |
|
|||||
|
2017
Q1 | $22.7M | Buy |
|
|||||
|
2016
Q4 | $18.5M | Sell |
|
|||||
|
2016
Q3 | $14.2M | Buy |
|
|||||
|
2016
Q2 | $2.58M | Sell |
|
|||||
|
2016
Q1 | $3.58M | Sell |
|
|||||
|
2015
Q4 | $5.96M | Buy |
|
|||||
|
2015
Q3 | $4.81M | Buy |
|